ESTRELLA IMMUNOPHARMA, INC. (ESLA) Operating cash flow 2021–2025
ESTRELLA IMMUNOPHARMA, INC. (ESLA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.8MFY2025 · since FY2021: -$316,158 → -$1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.8M | — |
| FY2023 | -$16.1M | -1102.6% |
| FY2022 | -$1.3M | -322.6% |
| FY2021 | -$316,158 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ESLA financial trends
ESLA RevenueESLA Net incomeESLA Net marginESLA Gross profitESLA Gross marginESLA Operating incomeESLA Operating marginESLA Free cash flowESLA Capital expendituresESLA Return on equityESLA Stock buybacksESLA Dividends paidESLA Total assetsESLA Total liabilitiesESLA Shareholders’ equityESLA overview →